Question 1

What are the potential side effects of bortezomib and cisplatin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer clinical trial (NCT06900647). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer clinical trial (NCT06900647). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the treatment schedule look like, and how often will I need to come in for visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer clinical trial (NCT06900647). Contact the study team or your healthcare provider for specific answers.

Question 4

What criteria will be used to determine if the treatment is working for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer clinical trial (NCT06900647). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific health requirements I need to meet to participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer clinical trial (NCT06900647). Contact the study team or your healthcare provider for specific answers.

Question 6

What support will be available to me during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer clinical trial (NCT06900647). Contact the study team or your healthcare provider for specific answers.

What this study is about